52North
52North develops in-vitro diagnostic and digital solutions designed to improve the safety and effectiveness of emergency care. The company's portfolio includes the Aster platform for portable cell measurement, the Neutrocheck finger-prick blood test for neutropenic sepsis risk, and the ACORN digital triaging tool for cancer patients. Their technology serves healthcare professionals and patients by enabling remote management and rapid biomarker testing.
Visit websiteCambridge, UK
Healthtech
Diagnostics
Digital Health
Medtech
Funding summary
- Total raised
- €5.7M
- Funding rounds
- 1
Investors in 52North
Investors on record for 52North. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like 52North?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors